Thrombophilic states. Thrombophilic state is characterized by a shift in the coagulation balance in favour of hypercoagulability – i.e. easier and oftener.

Slides:



Advertisements
Similar presentations
Chapter 12 Disorders of Hemostasis
Advertisements

Mechanisms of disease in the antiphospholipid syndrome A short tributededicated to the memory of Dr. Virgil Woods Jr.: brilliant and generous scientist,
Thrombophilia. Now considered a multicausal disease, with an interplay of acquired and genetic thrombotic risk factors Approximately half of venous thromboembolic.
Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
HAEMATOLOGY MODULE: COAGULATION DISORDERS 1 Adult Medical-Surgical Nursing.
Vascular Pharmacology
Pathology of Coagulation I- Deficiency of Coagulation Factors II- II- HYPERCOAGULABLE STATES.
Pathology 430/826 Thrombosis David Lillicrap. Cardiovascular Disease 30% of all deaths in Canada 54% ischemic heart disease 20% stroke 23% heart attack.
Below the Knee DVT and Pregnancy Related Thrombosis Robert Lampman, MD Morning Report July 2009.
Asilmi HEMOSTASIS Ahmad Shihada Silmi Faculty of Sciences IUG Med. Tech. Dep. Room # B326.
Blood S-J Tsai Department of Physiology. Composition Composed of cells (erythrocytes, leukocytes, and platelets) and plasma (the liquid in which the cells.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
Week 7: Fibrinolysis and Thrombophilia Secondary fibrinolysis Secondary fibrinolysis Primary fibrinolysis Primary fibrinolysis Plasminogen Plasminogen.
Hemodynamic Tutorial.
Dr MOHAMMED H SAIEMALDAHR FACULTY of Applied Medical Sciences
The Human Circulatory System
Chapter Two Venous Disease Coalition Pathogenesis and Consequences of VTE VTE Toolkit.
Thrombophilias Sharon Sams. Objectives Overview of etiology of hypercoagulability Available tests Clinical correlation or “What do I do with these results?”
DVT: Symptoms and work-up Sean Stoneking. DVT Epidemilogy Approximately 600,0000 new cases of DVT each year 50% in hospitalized patients or nursing home.
Dr Nico Lategan MBChB, MMed (Haematology)
FUNCTIONS OF THE COAGULATION SYSTEM ACTIONDESIRED RESULT Rapid formation of mechanically sound clot Stop bleeding quickly Prevent clot formation at non-injured.
Implant of a Medical Device and the Wound Healing Process.
Anti-phospholipid syndrome Clinton Mitchell 5th year Haematology.
Thrombophilia— Hypercoagulable States Gabriel Shapiro, MD, FACP.
Dr Mahvash Khan MBBS, MPhil. ◦ Occurs inside the blood vessels, it is also called fibrinolysis ◦ Occurs due to a substance known as plasmin (fibrinolysin)
1 HAEMOSTASIS. 2 Definition Haemostasis is a complex sequence of physical and biochemical changes induced by damage to tissues and blood vessels, which.
Coagulation Concepts A review of hemostasis Answers are in the notes pages.
Haemostasis Presented by Dr Azza Serry. Learning Objectives  Definition.  Clotting mechanism.  What keeps blood in fluid status  Control of blood.
Thrombophilia (Hypercoagulable States)
Diagrams from Wednesday
DIC disseminated intravascular coagulation DIC is characterized by widespread coagulation and bleeding in the vascular compartment. DIC begins with massive.
BLOOD. Blood Complex mixture of cells, cell fragments, and dissolved biochemicals that transports nutrients, oxygen, wastes, and hormones Complex mixture.
THROMBOSIS Dr. Afsar Saeed Shaikh M.B.B.S, M.Phil. Assistant Professor of Chemical Pathology Pathology Department, KEMU, Lahore.
Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 3 rd Year – Level 5 – AY
Thrombophilia National Haemophilia Director
Thrombophilia (Hypercoagulable States) Abdulkareem Almomen, MD Professor of Medicine & Hematology, King Saud University MED 341, Feb.2014.
Thrombophilia. Definition –Tendency to develop clots due to predisposing factors that may be genetically determined.
Clot Formation Review with Animations
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Beginning of the chapter Thrombosis and genetics (Thrombo Sensor) 36.
Protein C.  Protein C is a major physiological anticoagulant. anticoagulant  It is a vitamin K-dependent serine protease enzyme, that is activated by.
LABORATORY DIAGNOSIS OF PROTHROMBOTIC STATES. REGULATION OF COAGULATION Introduction Coagulation necessary for maintenance of vascular integrity Enough.
Deep vein thrombosis and pulmonary embolism.
Introduction to Haemostasis Ahmad Sh. Silmi Hematologist Msc,FIBMS.
Haemostasis. Indications for hemostasis test – Identify patients presenting with bleeding that have a correctable bleeding tendency – Identify patients.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 26 Disorders of Hemostasis.
Thrombosis and Haemostasis Café Cardiologique 29/10/2014.
Course Lecturer: Imon Rahman
Nephrotic syndrome & Thromboembolic complications 신장내과 R3 김진숙 / Prof. 임천규 R3 김진숙 / Prof. 임천규.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
Venous Thromboembolism-1
Thrombosis.
Hypercoagulable States
Discounted Coagulation Profiles Clinical Laboratories.
Implant of a Medical Device and the Wound Healing Process.
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Answer the 20 questions!.
Fundamentals of Medicine: Haematology
Nat. Rev. Nephrol. doi: /nrneph
Mechanisms of disease in the antiphospholipid syndrome
Drugs Affecting Blood.
Thrombophilia.
Thrombosis and Inflammatory Bowel Disease
THROMBOSIS.
Hemostasis Hemostasis depends on the integrity of Blood vessels
Mechanisms of disease in the antiphospholipid syndrome
HUS and atypical HUS by T. Sakari Jokiranta Blood
Myeloproliferative neoplasms and thrombosis
Presentation transcript:

Thrombophilic states

Thrombophilic state is characterized by a shift in the coagulation balance in favour of hypercoagulability – i.e. easier and oftener formation of the blood coagulum is characterized by a shift in the coagulation balance in favour of hypercoagulability – i.e. easier and oftener formation of the blood coagulum inborn (genetically determined) inborn (genetically determined) acquired acquired

Acquired thrombophilic state Thrombophilic reaction is a part of the complex inflammatory and stress response of the organism, and a part of the phylogenetic adaptation in order to deal with presumed damage of the organism. Thrombophilic reaction is a part of the complex inflammatory and stress response of the organism, and a part of the phylogenetic adaptation in order to deal with presumed damage of the organism.

The inflammatory states are accompanied by the following phenomena: The inflammatory states are accompanied by the following phenomena: increased expression of selectins (selectin E on endothelial cells, selectin L on leukocytes, selectin P on platelets and endothelial cells) increased expression of selectins (selectin E on endothelial cells, selectin L on leukocytes, selectin P on platelets and endothelial cells) increased expression of integrins (ICAM-1 and VCAM-1 on endothelial cells, LFA-1 on leukocytes) increased expression of integrins (ICAM-1 and VCAM-1 on endothelial cells, LFA-1 on leukocytes) mutual interactions of adhesion molecules induce adhesion and activation of endothelial and inflammatory cells that are stimulated to produce PAF (platelet activating factor) with a subsequent adhesion of platelets to endothelium, releasing vWf. mutual interactions of adhesion molecules induce adhesion and activation of endothelial and inflammatory cells that are stimulated to produce PAF (platelet activating factor) with a subsequent adhesion of platelets to endothelium, releasing vWf.

Virchow`s triad 1/ Changes in the pattern of blood flow (flow volume) permanent dilution of coagulation and fibrinolytic factors 2/ Changes in the vessel wall intact endothelium has antithrombotic and anticoagulation effects (endothelial dysfunction causes thrombophilia) 3/ Changes in the constituents of blood (hypercoagulability) inflammatory reactions, inborn thrombophilic states inflammatory reactions, inborn thrombophilic states

Clinical situations accompanied by thrombophilia: Clinical situations accompanied by thrombophilia: infections infections tumours, incl. haematological malignancies (often the tumours, incl. haematological malignancies (often the first sign of the tumour) first sign of the tumour) operations operations hormonal contraception hormonal contraception

* routine examinations: serum levels of CRP, fibrinogen, platelet count, D-dimers * special examinations: serum levels of selectins and integrins – not available in common laboratories Laboratory diagnostics:

Types of the thrombi white thrombus arterial (platelets – leukocytes – fibrinogen) with small participation of plasma coagulation factors (blood flow washes and dissolves them) - can be also formed on the intact endothelium at „shear stress“, that leads to its activation (platelets being activated as well) and expression of adhesion molecules with a subsequent cascade of thrombophilic reactions stress“, that leads to its activation (platelets being activated as well) and expression of adhesion molecules with a subsequent cascade of thrombophilic reactions

Clinical situations caused by the white thrombus: acute coronary syndromes acute coronary syndromes arterial thromboses arterial thromboses ischaemic brain strokes ischaemic brain strokes

red thrombus venous (fibrin – erythrocytes) - often caused by slowing down of the blood flow Clinical situations caused by the red thrombus:  deep venous thrombosis (DVT) of the lower extremities  pulmonary embolization (PE)

Clinically important thrombophilic states

APC resistance inborn disease inborn disease mutation of the Leiden factor V mutation of the Leiden factor V Cambridge mutation of the factor V Cambridge mutation of the factor V decreased level of the factor V decreased level of the factor V Examinations: coagulation – aPTT coagulation – aPTT PCR – mutation of the Leiden factor PCR – mutation of the Leiden factor

Hyperhomocysteinaemia inborn inborn acquired acquired Homocysteine is an intermediate product of the metabolism of the essential amino acid methionine. - risk factor for the development of arterial and venous thrombosis thrombosis Therapy: folates + vitamin B

Antiphospholipid syndrome (Hughes syndrome) - acquired - multiple different antibodies associated with both arterial and venous thrombosis - primary – three primary classes of antibodies: 1) anticardiolipin antibodies (ACLA) 1) anticardiolipin antibodies (ACLA) 2) lupus anticoagulant (LA) 2) lupus anticoagulant (LA) 3) antibodies directed against specific molecules, 3) antibodies directed against specific molecules, incl. a molecule known as beta-2-glycoprotein 1 incl. a molecule known as beta-2-glycoprotein 1 - secondary – accompanying diseases, such as SLE or other autoimmune diseases, leukaemias, lymphomas

Other inborn thrombophilic states deficit of the protein C deficit of the protein C deficit of the protein S deficit of the protein S deficit of antithrombin III deficit of antithrombin III increased level of prothrombin increased level of prothrombin deficit of thrombomodulin deficit of thrombomodulin increased level of factors VIII, IX, XI, fibrinogen increased level of factors VIII, IX, XI, fibrinogen

Antithrombogenic mutations mutation of Annexin V mutation of Annexin V antithrombogenic mutation may counterbalance thrombophilic mutation in clinical practice and neutralize its thrombophilic effects. antithrombogenic mutation may counterbalance thrombophilic mutation in clinical practice and neutralize its thrombophilic effects.